Αποτελέσματα Αναζήτησης
25 Μαΐ 2023 · Chemotherapy success rates and cancer survival rates can vary. This article outlines the use of chemotherapy drugs in the treatment of different cancers. We describe how many people with...
23 Ιουν 2022 · Testicular cancer survival has increased from 83% in patients who were diagnosed during the mid-1970s to 95% in the most recent time period, largely because of the success of chemotherapy regimens for advanced disease.
7 Αυγ 2019 · The overall cancer incidence rate is 16% higher in white men than in non-Hispanic black (black) men, who have the second highest rate, largely driven by higher rates of urinary bladder cancer, melanoma, and non-Hodgkin lymphoma.
Results. Of the 4689 patients treated with chemotherapy over the 5 year period, 133 patients (3%) were ≥ 80 years old. The median age was 83 years. 61% were females and 39% were males. 16% had hematologic tumors and 84% had solid tumors.
26 Αυγ 2020 · Patients who received chemotherapy tended to be younger (age 74 versus age 78 years), had higher-grade disease (grade 3), larger primary tumors (pT3/T4), had a higher degree of nodal burden (stage pN3), and were more likely to receive radiation therapy (67.4% vs. 43.5%) and endocrine therapy (88.3% vs. 82.5%).
Available information on long-term and late effects of cancer and its treatment, recurrence and subsequent cancers, financial hardships, and health behaviors among cancer survivors is also presented. Figure 1. Estimated Number of US Cancer Survivors by Site.
11 Ιουν 2019 · The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females.
